CFO Rubinstein Acquires 90,750 Of Adverum Biotechnologies Inc [ADVM]
I'm PortAI, I can summarize articles.
Rubinstein Linda M Chief Financial Officer of Adverum Biotechnologies Inc [ADVM] filed a Form 4 on December 10, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/9/25TransactionExerciseShares90,750Price$2.26Value$204,750Ending Holdings: 0 - DirectFor a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments